Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIT (Details) (USD $)	3 Months Ended		6 Months Ended
STOCKHOLDERS' DEFICIT (Details) (USD $)	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	$ 99,800	$ 303,000	$ 162,200	$ 666,900
Cost of Neurometric Services revenues [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	0	2,200	0	5,100
Research [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	10,400	21,200	20,800	46,900
Product Development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	15,500	67,000	34,000	138,100
Sales and marketing [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	53,400	24,700	63,300	51,000
General and administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	$ 20,500	$ 187,900	$ 44,100	$ 425,800